Dallas, Tx. (PRWEB) May 21, 2013
Dallas-based TopMD™ Skin Care today announced results of its first peer- reviewed journal article testing the efficacy of their flagship product, CLn® BodyWash for easing symptoms of eczema. The clinical study results appear in the May/June 2013 issue of Pediatric Dermatology.
The article, “A Novel Sodium Hypochlorite Cleanser Shows Clinical Response and Excellent Acceptability in the Treatment of Atopic Dermatitis,” reports impressive findings seen after consistent use of the product by 18 pediatric patients with eczema.
Eczema is a chronic, inflammatory skin condition marked by red, itchy rashes affecting millions of Americans, including a disproportionate number of children, and can have a significant impact on quality of life.
“I’m extremely pleased that study participants saw such a marked improvement,” said Dr. Caitriona Ryan, who was the lead author of the study. “There are few effective non-antibiotic, non-steroidal treatment options for families dealing with eczema, and this product gives them an alternative to the commonly prescribed bleach bath, filling an important gap in the market.”
CLn BodyWash is a gentle, non-drying wash designed to cleanse skin prone to eczema, acne, infection and folliculitis. Texas cardiologist Dr. Azam Anwar created the product after his own experience with cellulitis. After realizing there were few effective treatments, he teamed up with friend and renowned dermatopathologist, Dr. Clay Cockerell. Their over-the-counter skincare solution, CLn BodyWash, has the benefits of a bleach bath, but the convenience and portability of a gel cleanser.
About the Clinical Study
Ryan, a dermatology resident at Baylor University Medical Center in Dallas, tracked 18 children ages 2 to 11 years with moderate to severe eczema over the past 18 months. Patients were instructed to wash with CLn BodyWash three days per week for the 12-week feasibility study while maintaining their prescribed topical and systemic treatments. Treatment response was measured using an Investigator Global Assessment (IGA) score and the percentage of body surface area (BSA) affected by eczema.
Dr. Ryan and her colleagues found a statistically significant reduction in the IGA score throughout the study, and the mean reduction in BSA affected from baseline to final measure in all patients was 14.8 percent.
Parents of children who participated in the study were enthusiastic about the success of CLn BodyWash in treating atopic dermatitis. Based on a questionnaire fielded at the conclusion of the study, when asked if they would recommend the product to friends or family (1 being “no way;” 10 being “definitely”), the mean response was 9.25 -- further validating excellent acceptability and tolerability to the sodium hypochlorite-based body wash.
Dr. Fred Ghali, expert pediatric dermatologist and clinical assistant professor of dermatology at University of Texas Southwestern Medical School in Dallas, served as senior author of the study.
“In the realm of atopic dermatitis and similar disorders of compromised skin, patients depend on a skin care regimen that is simple yet effective,” Ghali said. “CLn BodyWash contains a unique blend of ingredients that is ideal for infection-prone skin as demonstrated in our recently published study.”
Dr. Lawrence Eichenfield, chief of pediatric and adolescent dermatology at Children's Hospital, San Diego and at the University of California, San Diego School of Medicine, was impressed by the results.
"I am excited to read the study by Dr. Ryan et al showing the benefits of TopMD's sodium hypochlorite-based body wash in patients with atopic dermatitis. The peer-reviewed article reinforces our clinical experience that this product can be very helpful in regimens of care for eczema,” concluded the past president of the Society for Pediatric Dermatology.
About TopMD Skin Care
Founded by Texas physicians, Azam Anwar, M.D., and highly regarded dermatopathologist Clay Cockerell, M.D., TopMD Skin Care released its premier product, CLn® BodyWash, in the first quarter of 2012. As an over-the-counter, non-prescription product, CLn BodyWash is an innovative, non-irritating gel cleanser designed to effectively cleanse skin prone to eczema, acne and folliculitis. Developed by dermatologists, the cleanser has been clinically tested to be safe and effective in children (6 months and older). CLn BodyWash can be used in the shower or bath – head to toe – and emulates the effectiveness of a “bleach bath” with greater convenience and portability. A complimentary product, CLn SportWash, was launched in the last quarter of 2012 and the CLn Facial Cleanser was launched in the second quarter of 2013.
CLn BodyWash and CLn SportWash received the National Eczema Association’s Seal of Acceptance. CLn products are currently sold in select physicians’ offices; online at http://www.clnwash.com; and at select pharmacies.